Office Address:
1161 21st Avenue South, Preston Research Building, Room / Suite D-3100 Medical Center North, Nashville, TN 37232

Hugh Jackson Morgan Chair in Medicine

Chair, Department of Medicine

Physician in Chief, Vanderbilt Hospital

Deputy Director for Research Integration and Career Development, Vanderbilt-Ingram Cancer Center

Professor, Biochemistry

Hometown
Sheffield, IA
Previous Institution
University of North Carolina at Chapel Hill
Previous Role/Title
Associate Professor of Medicine
Specialty
Oncology/Urology

Education

MD - Stanford University, Stanford, California, 1998
PhD - Stanford University, Stanford, California, 1996
BA - University of Northern Iowa, Cedar Falls, Iowa, 1991
BS - University of Northern Iowa, Cedar Falls, Iowa, 1991

Postgraduate Training

Internship

University of Chicago Medical Center, 1999

Fellowship

Hematology/Oncology - University of Pennsylvania, 2003

Board and Certifications

Medical Oncology - American Board of Internal Medicine, 2004

Professional Highlights

Dr. Kimryn Rathmell is the Chair of Medicine and Physician-in-Chief at Vanderbilt University Medical Center.  She is a physician-scientist studying the molecular biology of renal cell carcinomas and rare tumors of the kidney. She earned her undergraduate degrees in Chemistry and Biology at the University of Northern Iowa, and her MD and PhD in Biophysics at Stanford University. She completed internal medicine training at the University of Chicago and the University of Pennsylvania, and fellowship in medical oncology at the University of Pennsylvania.  She joined the Departments of Medicine and Genetics at the University of North Carolina in 2003 and was a founding member of the Department of Urology before relocating to Vanderbilt in 2015.

Clinical Interest

As a genitourinary oncologist, I focus on renal cell carcinoma.

Areas of Expertise

Cancer
Genetics
Medical Oncology
Prostate, Bladder, and Kidney Cancer
Urologic/Genitourinary Cancer

Location

Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
2220 Pierce Avenue
Nashville, TN 37232
(map)
Research Keywords
Renal cell carcinoma
Research Description
Her research program focuses on understanding the molecular pathogenesis of renal cell carcinomas and spans early models of renal tumorigenesis, novel imaging strategies for diagnosis and screening of kidney cancer, epigenetic regulation of kidney cancers, metabolic features of tumorigenesis, and novel therapeutic strategies to overcome resistance to anti-angiogenic therapy and checkpoint targeted immunotherapy. With these bench to bedside strategies, her laboratory endeavors to integrate knowledge of pathways that promote cancer development with translational clinical studies, and uses these discoveries to develop robust approaches to improve the survival of patients with kidney cancers. She is also deeply committed to the development of physician-scientists. At UNC Chapel Hill, she worked closely with the Medical Scientist Training program, founded the oncology junior faculty mentoring program, and served the Lineberger Comprehensive Cancer Center as Associate Director for Education and Training. At Vanderbilt, she serves as the Deputy Director for Research Integration and Career Development for the Vanderbilt-Ingram Cancer Center. She directs T32 and K12 career development programs, in addition to continuing to serve as a faculty mentor for the Vanderbilt Medical Scientist Training Program. Outside of these activities, she has led organizational initiatives through such work as service on the ASCO Ethics and Education Committees, chaired the ASCO Nominating Committee, founded and served as chair for the Department of Defense Kidney Cancer Research Program, led numerous working groups of the NIH Cancer Genome Atlas (TCGA), served on several editorial boards, most recently the Journal of Clinical Investigation, Cancer Research, and the Journal of Clinical Oncology-Precision Oncology, and served on the ASCI Council as Secretary-Treasurer and President of the Society, leading changes for young physician-scientists, enhancing advocacy and development, and during the founding of the second journal of the society, JCI-Insight. Dr. Rathmell currently serves on the Board of Scientific Advisors for the National Cancer Institute.